Tirofiban is superior to aspirin in non-obstructive strokes

Published Date: 08 Mar 2023

Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.

Read Full News

Latest News

Rabies in an 11-Year-Old Boy After Bat Contact

Early facial numbness and sore gums masked a deadly diagnosis in a boy who had direct bat contact but no obvious wound.

Vitiligo Severity Assessments Vary Among HCPs

US and Europe healthcare providers describe inconsistent approaches to nonsegmental vitiligo severity, with quality of life, repigmentation, and progression influencing treatment decisions.

Wheat Sensitivity: Is Gluten the Only Trigger?

Symptoms associated with wheat sensitivity may involve more than gluten, making careful testing important before dietary restriction and limiting reliance on self-diagnosis.

Schools Need Proactive Asthma Care Plans

Fewer than a third of children’s schools are equipped to manage emergent asthma exacerbations, a study shows.

Race and Language May Shape Kids’ Asthma ED Care

Race, gender, language, and chronic illness may influence hospital outcomes after an ED visit for asthma, but the standard social drivers of health indices miss geographic patterns behind it.

Experts: States Not Likely to Change Vaccine Policy After EO

An Executive Order implicitly threatened states that do not align with its recommendations, but experts say the administration would be on shaky legal ground.

Todays Updates

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Todays Updates

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Latest News

Early facial numbness and sore gums masked a deadly diagnosis in a boy who had direct bat contact but no obvious wound.

US and Europe healthcare providers describe inconsistent approaches to nonsegmental vitiligo severity, with quality of life, repigmentation, and progression influencing treatment decisions.

Symptoms associated with wheat sensitivity may involve more than gluten, making careful testing important before dietary restriction and limiting reliance on self-diagnosis.

Fewer than a third of children’s schools are equipped to manage emergent asthma exacerbations, a study shows.

Race, gender, language, and chronic illness may influence hospital outcomes after an ED visit for asthma, but the standard social drivers of health indices miss geographic patterns behind it.

An Executive Order implicitly threatened states that do not align with its recommendations, but experts say the administration would be on shaky legal ground.

News All Time

Pediatric CRRT: Fluid Overload, Lung Injury Not Culprits

In children and young adults with acute lung injury requiring CRRT, neither the severity of lung injury nor the degree of fluid accumulation at treatment initiation predicted prognostic outcomes.

Mpox Presenting as Proctitis in a Man

Severe rectal pain and proctitis may be the first signs of mpox, even before rash appears, making early PCR testing crucial in unexplained cases.

Doctors Must Decide When to Trust AI — And When Not To

Physicians increasingly use AI as a valued tool. Their patients also use it but may need help to evaluate its output. Here, Robert Wachter, MD, of UCSF, shares his views.

Virtual Nephrologist Boosts Transplant Discussions in CKD

An AI intervention increases patients’ intention to discuss kidney transplantation with a clinician and may help overcome access barriers to transplant education.

Pediatric Hepatitis Outbreaks: Scrutinizing Acetaminophen

From Reye syndrome to modern hepatitis clusters, over-the-counter drug exposure keeps escaping scrutiny simply because we fail to record it.

SMC OKs First C5 Inhibitor for Refractory Myasthenia Gravis

The SMC has recommended zilucoplan for use in NHS Scotland as an add-on therapy for adults with treatment-resistant myasthenia gravis.

TB Vaccine Pipeline Enters Most Promising Phase in Decades

Eighteen tuberculosis vaccine candidates are now in clinical development, with several in or approaching late-stage trials and the leading candidate securing a manufacturer.

Cyclosporiasis: When the Chart Says Sulfa Allergy

The recent outbreak of Cyclospora cayetanensis raises the question of how to treat patients with sulfa allergic reactions, and whether to test if the allergy is accurate.

Dupilumab Improves Allergic Fungal Rhinosinusitis Outcomes

Dupilumab significantly improves sinus opacification and disease burden in patients with allergic fungal rhinosinusitis.

Fecal Transplant Raises Peanut Tolerance

Oral fecal microbiota transplant raises the amount of peanut that some highly allergic adults can tolerate, serving as proof of concept for microbiome-based food allergy therapy.

Dupilumab Shows Long-Term Benefits in CRSwNP

Dupilumab yields sustained benefits in terms of nasal congestion, sense of smell, and quality of life in patients with CRSwNP over 24 months in a real-world global registry.

Childhood Lupus: High Disease Activity Persists in Adulthood

Adults with childhood-onset systemic lupus erythematosus face a strikingly different disease trajectory than those diagnosed later in life, spending less time in the low disease activity state.

First Dust Mite Immunotherapy Cleared for Scotland

Acarizax is now the first house dust mite immunotherapy accepted by the SMC for patients with persistent allergic rhinitis.

Comparative CV Effectiveness of GLP-1s and SGLT2 Inhibitors in T2DM

A multinational, retrospective, new-user active-comparator cohort study using 10 U.S. and non-U.S. administrative claims and EHR databases.

New Score Predicts Mortality Post-Liver Transplant in Kids

A new sepsis score accurately identifies children with the highest risk for mortality after liver transplantation and infection.

Cough Headaches: Should Evaluation Stop at Brain MRI?

Although Chiari malformation is a common cause, persistent cough headaches may also indicate cerebrospinal fluid disorders, vascular lesions, or other structural abnormalities.

Recommended News For You

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

Older Adults With Advanced Cancer Prioritize Quality of Life

FDA approves rivanetin as the first-line treatment for lung cancer.

Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

Higher levels of HIF2α found to slow down aggressive childhood cancer

Recommended Articles For You

The Benefits and Risks of Thrombolytics: A Comprehensive Guide  

Comprehensive Updates in Hematology and Quality Improvement 

The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies 

Rehabilitation of Physical Endurance Following Prolonged Cytopenic States 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca

2.

One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study

3.

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

4.

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

5.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

1.

Emerging Advances in Hematology and Quality Improvement

2.

Practical Breakthroughs in Oncology Across Clinical Settings

3.

Nuclear Medicine's Role in Battling Women's Cancers

4.

Genetic Screening: A Game Changer in Cancer Prevention

5.

Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part VII

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

3.

Signs and Symptoms of Leukemia

4.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot